BIotechnology and IP – A presentation by Dr. Kalyan C. Kankanala
Biotechnology and IP
Read MorePosted by sinapse on Mar 19, 2013
Australian Federal Court upholds BRCA1 gene as patent worthy
In the landmark Australian case, Cancer Voices Australia (ABN 93 322 703 427) & Anor v Myriad Genetics Inc & Ors, the Federal Court of Australia has ruled in...
Read MoreLaws of Nature / State of Art Interface
The laws of nature exclusion is one of the basic exceptions to patent eligibility in many jurisdictions. While the extent of its applicability may vary from country to...
Read MoreMonsanto Soybean Roundup technology:Farmers Seed(k)ing justice
There has always been a great deal of controversy surrounding Monsanto and their products, specially the genetically engineered seeds. It has received all the attention...
Read MoreMyriad Genetics- Gene Patent Litigation
Patenting of genes has always been the most controversial and debatable topic ever since Diamond v. Chakrabarty case on genetically-engineered bacterium for cleaning up...
Read More